Skip to content
healthcare.dev
Get a free key

Roflumilast

NDC 68382-969, Roflumilast, tablet, from Zydus Pharmaceuticals USA Inc..

Product NDC
68382-969
Status
Listed
Labeler
Zydus Pharmaceuticals USA Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208303
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68382-969 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ROFLUMILAST500 ug/1

Pharmacologic classes

Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]

Package NDCNDC-11Package
68382-969-066838209690630 TABLET in 1 BOTTLE (68382-969-06)
68382-969-166838209691690 TABLET in 1 BOTTLE (68382-969-16)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/84145572-f320-4c3f-ab29-bd9f6c18746c

  • NADAC price for package 68382096906

    GET /v1/drugs/nadac/68382096906

  • NADAC price for package 68382096916

    GET /v1/drugs/nadac/68382096916

Use it

Look up 68382-969 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68382-969 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68382-969. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.